IRIS
GRASSO, Silvana
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 17.766
EU - Europa 11.246
AS - Asia 5.990
SA - Sud America 2.086
AF - Africa 184
Continente sconosciuto - Info sul continente non disponibili 13
OC - Oceania 9
AN - Antartide 1
Totale 37.295
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 17.618
RU - Federazione Russa 5.380
SG - Singapore 2.357
BR - Brasile 1.833
CN - Cina 1.595
IE - Irlanda 1.461
SE - Svezia 1.244
VN - Vietnam 902
UA - Ucraina 728
IT - Italia 627
DE - Germania 597
HK - Hong Kong 534
FR - Francia 328
FI - Finlandia 303
GB - Regno Unito 264
IN - India 145
AR - Argentina 81
TR - Turchia 69
BD - Bangladesh 67
CA - Canada 66
AT - Austria 51
IQ - Iraq 48
ZA - Sudafrica 47
MX - Messico 44
CZ - Repubblica Ceca 42
EC - Ecuador 42
MA - Marocco 41
BE - Belgio 40
NL - Olanda 40
UZ - Uzbekistan 38
CO - Colombia 34
PL - Polonia 32
VE - Venezuela 30
PK - Pakistan 29
ID - Indonesia 25
IR - Iran 25
ES - Italia 23
CL - Cile 19
JP - Giappone 19
TN - Tunisia 19
SA - Arabia Saudita 17
PE - Perù 16
AE - Emirati Arabi Uniti 15
DZ - Algeria 15
PY - Paraguay 15
CI - Costa d'Avorio 14
JM - Giamaica 12
NP - Nepal 12
UY - Uruguay 12
LV - Lettonia 11
RO - Romania 11
CH - Svizzera 10
IL - Israele 10
KE - Kenya 10
AZ - Azerbaigian 9
EG - Egitto 9
GE - Georgia 9
EU - Europa 8
MY - Malesia 8
SN - Senegal 8
AU - Australia 7
KG - Kirghizistan 7
LT - Lituania 7
BY - Bielorussia 6
JO - Giordania 6
KZ - Kazakistan 6
PA - Panama 6
AL - Albania 5
AM - Armenia 5
BA - Bosnia-Erzegovina 5
DO - Repubblica Dominicana 5
KR - Corea 5
TT - Trinidad e Tobago 5
AO - Angola 4
ET - Etiopia 4
HN - Honduras 4
KW - Kuwait 4
LB - Libano 4
PH - Filippine 4
TH - Thailandia 4
A2 - ???statistics.table.value.countryCode.A2??? 3
BO - Bolivia 3
CR - Costa Rica 3
DK - Danimarca 3
EE - Estonia 3
GR - Grecia 3
LU - Lussemburgo 3
OM - Oman 3
RS - Serbia 3
BG - Bulgaria 2
GA - Gabon 2
HU - Ungheria 2
LY - Libia 2
MD - Moldavia 2
ML - Mali 2
NG - Nigeria 2
PT - Portogallo 2
SY - Repubblica araba siriana 2
XK - ???statistics.table.value.countryCode.XK??? 2
AD - Andorra 1
Totale 37.269
Salva come PNG Salva come JPEG
Città #
Dallas 9.883
Moscow 1.695
Dublin 1.459
Jacksonville 1.380
Singapore 1.226
Chandler 949
Ashburn 821
Nyköping 812
Dong Ket 629
Beijing 538
Hong Kong 531
Princeton 265
The Dalles 256
Cambridge 254
San Jose 238
Medford 232
Lauterbourg 219
Dearborn 216
Des Moines 189
Los Angeles 188
Boardman 152
Ann Arbor 143
Messina 140
São Paulo 121
Buffalo 113
Ho Chi Minh City 98
Milan 98
Tianjin 95
Munich 89
San Mateo 75
New York 71
Lancaster 69
Jinan 68
Hanoi 61
Guangzhou 60
Wilmington 58
Redondo Beach 57
Rio de Janeiro 55
Woodbridge 54
Belo Horizonte 50
Vienna 48
Shenyang 45
Brooklyn 36
Brussels 36
Nanjing 36
Tashkent 36
Brno 35
Houston 35
Porto Alegre 34
Orem 33
Frankfurt am Main 32
Shenzhen 32
Augusta 30
Amsterdam 28
Warsaw 28
Haikou 27
Johannesburg 27
Hyderabad 26
Pune 26
Zhengzhou 26
Chicago 25
Helsinki 24
Santa Clara 24
Stockholm 24
Brasília 23
Campinas 23
Seattle 23
Chennai 22
Montreal 22
Curitiba 21
Fuzhou 21
Taizhou 21
Turku 21
Hebei 19
London 19
Mumbai 19
Ningbo 19
Salvador 19
St Petersburg 19
Ardabil 18
Baghdad 18
Shanghai 18
Changsha 17
Tokyo 17
Boston 16
Istanbul 16
Quito 16
Da Nang 15
Denver 15
Nanchang 15
Norwalk 15
Nuremberg 15
Rome 15
Abidjan 14
Dhaka 14
Guarulhos 14
Haiphong 14
Manaus 14
Poplar 14
Toronto 14
Totale 25.095
Salva come PNG Salva come JPEG
Nome #
[1,2,4]Oxadiazolo[5,4-d][1,5]benzothiazepines: synthesis and stereochemistry 4.725
[1,2,4]Oxadiazolo[5,4-d][1,5]benzothiazepines: stereochemistry and anticonvulsant activity 4.705
1-aryl-3,5-dihydro-4H-2,3-benzodiazepin-4-ones: Novel AMPA receptor antagonists 296
1-Phenyl-substituted 1H,3H-thiazolo[3,4-a]benzimidazoles and pharmaceutical compositions containing them 287
1-Halophenyl-N-N'-di-(2-heteroaryl)-methylenediamine and 1-halophenyl-3-(2-heteroaryl)-thiazolidin-4-ones as potential hypotensive agents. 277
1-Aryl-3,5-dihydro-4H-2,3-benzodiazepin-4-ones: non-competitive AMPA receptors antagonists 267
1-(2-Fluorophenyl)- and 1-(3-fluorophenyl)-1H,3H-thiazolo[3,4- a]benzimidazole 257
1-Aryl-6,7-methylenedioxy-3H-quinazolin-4-ones as anticonvulsant agents 253
1-Adamantanamine derivatives as potential anti-HIV agents 249
1-Halophenyl-N-N'-di-(2-heteroaryl)-methylenediamine and 1-halophenyl-3-(2-heteroaryl)-thiazolidin-4-ones as potential hypotensive agents. 249
1H,3H-Thiazolo[3,4-a]benzimidazoles and pharmaceutical compositions containing them 235
2,3,3a,4-Tetraidro-1H-pirrolo[1,2-a]benzimidazol-1-oni 3a-sostituiti 197
7,8-methylenedioxy-4H-2,3-benzodiazepin-4-ones as novel AMPA receptor antagonists 197
3H-AZIRINO[1,2-D][1,4]BENZODIAZEPIN-4 (5H)-ONES - SYNTHESIS AND STEREOCHEMISTRY 190
5H-[1,2,4]OXADIAZOLO[5,4-D][1,5]BENZOTHIAZEPINES - SYNTHESIS AND STEREOCHEMISTRY 188
2,3,3a,4-Tetraidro-1H-pirrolo[1,2-a]benzimidazol-1-oni isomeri ottenuti da 4-cloro-1,2-fenilendiamina ed acidi 3-acilpropionici 186
5H-[1,2,4]Oxadiazolo[5,4-d][1,5]benzothiazepines as anticonvulsant agents in DBA/2 mice. 186
Cap. 21 - Antitrombotici 185
3H-Azirino[1,2-d][1,4]benzodiazepin-4(5H)-ones: synthesis and stereochemistry 184
Identification of 2-thioxoimidazolidin-4-one derivatives as novel noncovalent proteasome and immunoproteasome inhibitors 184
3,5-Dihydro-5-methyl-7,8-methylenedioxy-4H-2,3-benzodiazepin-4-ones as novel noncompetitive AMPA receptor antagonists 177
Constrained peptidomimetics as antiplasmodial falcipain-2 inhibitors 175
2,3-Benzodiazepines as potential AMPA receptors antagonists 169
4,4-Methylenedioxybenzene derivatives: synthesis and investigation of the mechanism of their anticonvulsant activity. 168
Design, synthesis and biological evaluation of novel dipeptide-like rhodesain inhibitors containing a conformationally constrained 3-bromoisoxazoline warhead 168
7,9-Dihydro-1,3-dioxolo[4,5-h][2,3]benzodiazepin-8(7H)-ones as anticonvulsant agents 167
Cross-Metathesis Reactions in the Synthesis of Constrained Dipeptide Mimics as Potent Falcipain-2 Inhibitors. 166
13C NMR study of tetrahydrothiazolo[3,2-d][1,4]benzodiazepin-3(2H)-ones. 162
Cross-Metathesis Reactions in the Synthesis of Constrained Dipeptide Mimics as Potent Falcipain-2 Inhibitors 162
Development of novel 1,4-benzodiazepine-based Michael acceptors as antitrypanosomal agents 159
A simple and efficient synthesis of GYKI 52466 and GYKI 52895 158
Sintesi ed attività anti-HIV di 1H,3H-tiazolo[3,4-a]benzimidazoli-sostituiti 158
DEVELOPMENT OF NOVEL PEPTIDOMIMETIC ANALOGUES OF A HIGHLY POTENT AND SELECTIVE FALCIPAIN-2 INHIBITOR CONTANING A VINYL ESTER MOIETY 156
Design, synthesis and molecular modeling studies on peptidomimetic vinyl esters as falcipan-2 inhibitors 156
Derivati adamantanici a potenziale attività antivirale. 155
Synthesis and biological evaluation of novel peptidomimetics as rhodesain inhibitors 155
Identification of noncovalent proteasome inhibitors with high selectivity for chymotrypsin-like activity by a multistep structure-based virtual screening 155
6,7-Methylenedioxyphtalazin-1(2H)-ones as novel and potent anticonvulsant agents 154
Annelated 1,5-benzothiazepines 150
Compounds with potential anti-tumor activity VII. Synthesis and anti-tumor activity of 1-aryl-N,N'-di(1,3,4-thiadiazol-2-yl)methylenediamines 149
Development of novel amides as non covalent inhibitors of immunoproteasome 148
ANNELATED 1,5-BENZODIAZEPINES .2. 6 MEMBERED RINGS 147
ANNELATED 1,5-BENZODIAZEPINES .1. 3-MEMBERED, 4-MEMBERED, AND 5-MEMBERED RINGS. 147
6,7-Methylenedioxyquinazolin-4-ones as Anticonvulsant Agents 146
AMINOPYRAZINYL DERIVATIVES - SYNTHESIS AND EVALUATION OF ANTIINFLAMMATORY AND RELATED ACTIVITIES 146
Evaluation of curcumin irreversibility 146
4,5-Methylenedioxybenzene derivatives: synthesis and investigation of the mechanism of their anticonvulsant activity. 145
Synthesis, Chiral Resolution and Pharmacological Evaluation of a 2,3-Benzodiazepine-Derived Noncompetitive AMPA Receptor Antagonist 143
G-Protein-Coupled Receptor Kinase 2 (GRK2) Inhibitors: Current Trends and Future Perspectives 143
6,7-Metilendiossiftalazin-1(2H)-oni: una nuova classe di potenti agenti anticonvulsivanti. 142
6,7-Methylenedioxyphthalazin-1(2H)-ones as novel and potent anticonvulsant agents 142
Falcipain-2 inhibitors 141
Drug combination studies of curcumin and genistein against rhodesain of Trypanosoma brucei rhodesiense 141
ANTICONVULSANT ACTIVITY OF PYRROLO[1',2'-1,2]IMIDAZO[4,5- B]PYRIDINES, PYRROLO[2',1'-2,3]IMIDAZO[4,5-C] PYRIDINES AND PYRROLO[2,1-F]PURINES IN DBA/2 MICE 140
Development of Novel Peptidomimetics Containing a VinylSulfone Moiety as Proteasome Inhibitors 138
Immunoproteasome-selective and non-selective inhibitors: A promising approach for the treatment of multiple myeloma. 137
Development of novel 1,4-benzodiazepines as antitrypanosomal agents 136
Identification of novel 5 arylidene-3-phenyl-2 thioxoimidazolidin-4-ones as inhibitors of the chymotrypsin-like activities of the constitutive and immuno-proteasomes 136
Ciclofunzionalizzazione di 1,4- e 1,5-benzodiazepine: sintesi e stereochimica di nuovi sistemi eteropoliciclici ottenuti per reazione con acidi mercaptoacetici 135
7-Chloro-1-(2,6-difluorophenyl)-1H,3H-thiazolo[3,4- a]benzimidazole and 1-(2,6-difluorophenyl)-6-methyl-1H,3H- thiazolo[3,4-a]benzimidazole 134
Novel peptidomimetics containing different α,β-unsaturated electrophilic functions, as falcipain-2 inhibitors 133
Anti-HIV agents .4. Synthesis and in vitro anti-HIV activity of novel 1-(2,6-difluorophenyl)-1H,3H-thiazolo[3,4- a]benzimidazoles 130
2,3-Benzodiazepine-based noncompetitive AMPAR antagonists: design, synthesis, binding affinity and mechanism of inhibition of the GluR2Qflip homomeric receptor channel 130
Development of novel N-3-bromoisoxazolin-5-yl substituted 2,3-benzodiazepines as noncompetitive AMPAR antagonists 129
Immunoproteasome-selective inhibitors: a promising strategy to treat hematologic malignancies, autoimmune and inflammatory diseases 128
Cross-metathesis reactions applications to the synthesis of peptidomimetics as potent falcipain-2 inhibitors 127
Anti-HIV agents II. Synthesis and in vitro anti-HIV activity of novel 1H,3H-thiazolo[3,4-a]benzimidazoles. 126
Design, synthesis and biological evaluation of peptidomimetics boronic acids targeting 20S proteasome 125
An unexpected reaction between 2,3-dihydro-2,2,4-trimethyl-1H-1,5-benzodiazepine and mercaptoacetic acid 125
Vincamina: sintesi e caratteristiche spettroscopiche 124
Anti-HIV agents. V. Synthesis, structure and in vitro anti-HIV activity of novel 1H,3H-naphtho[2 ',3 ': 4,5]imidazo[1,2- c]thiazoles 122
Peptidomimetics containing a vinyl ketone warhead as falcipain-2 inhibitors 122
Development of peptidomimetic boronates as proteasome inhibitors 121
Development of Novel Selective Peptidomimetics Containing a Boronic Acid Moiety, Targeting the 20S Proteasome as Anticancer Agents 121
Development of peptidomimetic boronates as proteasome inhibitors 120
Development of novel dipeptide-like rhodesain inhibitors containing the 3-bromoisoxazoline warhead in a constrained conformation 120
STRATEGIES FOR SYNTHESIS OF CONFORMATIONALLY CONSTRAINED GLUTAMATE ANALOGUES 119
Glutamate Binding-Site Ligands of NMDA Receptors 119
Development of Novel Peptide-based Michael Acceptors Targeting Rhodesain and Falcipain-2 for the Treatment of Neglected Tropical Diseases (NTDs) 119
Novel potent AMPA/kainate receptor antagonists: Synthesis and anticonvulsant activity of a series of 2-[(4- alkylsemicarbazono)-(4-aminophenyl)methyl]-4,5- methylenedioxyphenylacetic acid alkyl esters 117
ANTI-HIV AGENTS .3. SYNTHESIS AND IN-VITRO ANTI-HIV ACTIVITY OF NOVEL 1H,3H-THIAZOLO[3,4-A]IMIDAZO[4,5-B]PYRIDINES 117
DEVELOPMENT OF NOVEL PEPTIDOMIMETICS CONTAINIG A VINYL SULFONE MOIETY AS PROTEASOME INHIBITORS 117
A simple, one-pot synthesis of novel 1H,3H-thiazolo[3,4-A]benzimidazoles 116
The Inhibition of Cysteine Proteases Rhodesain and TbCatB: A Valuable Approach to Treat Human African Trypanosomiasis 116
Sintesi ed attività anti-HIV di 1H,3H-tiazolo[3,4-a]benzimidazoli 1-sostituiti 114
Synthesis and Molecular Modeling Studies of Derivatives of a Highly Potent Peptidomimetic Vinyl Ester as Falcipain-2 Inhibitors 113
Composti a presumibile attività antitumorale. IV - Sintesi ed attività antileucemica di N,N'-di-[2-(1,3,4-tiadiazolil)]metilendiamine 1-sostituite 112
Synthesis of novel peptidomimetics as inhibitors of protozoan cysteine proteases falcipain-2 and rhodesain 112
Novel peptidomimetics as antiplasmodial falcipain-2 inhibitors 112
C-13 NMR-study of tetrahydrothiazolo-[2,3-D][1,4]benzodiazepin-3(2H)-ones 112
Sintesi ed attività di nuovi agenti antiipertensivi. 111
Compounds with potential antitumor activity. Note VIII 1-Alkyl-N,N'-di(1,3,4-thiadiazol-2-yl)methylenediamines. 111
Structure-activity study of 2,3-benzodiazepin-4-ones noncompetitive AMPAR antagonists: identification of the 1-(4-amino,3-methylphenyl)-3,5-dihydro-7,8-ethylenedioxy-4H-2,3-benzodiazepin-4-one as neuroprotective agent 111
The reaction between 3-acylpropionic acids and the o-phenylenediamine: n.m.r and X-ray analysis of 3a-phenyl-2,3,3a,4-tetrahydropyrrolo[1,2-a]benzimidazol-1-one. 110
Sintesi e proprietà anticonvulsivanti di 3-(1,3,4-tiadiazol-2-il)tiazolidin-4-oni. 110
Optimization of peptidomimetic boronates bearing a P3 bicyclic scaffold as proteasome inhibitors 110
Development of novel peptide-based Michael acceptors targeting rhodesain and falcipain-2 for the treatment of neglected tropical diseases (NTDs) 110
Synthesis and biological activity of novel 1H,3H-thiazolo[3,4- a] benzimidazoles: non-nucleoside human immunodeficiency virus type 1 reverse transcriptase inhibitors 109
Reazioni di cross metathesis: applicazione alla sintesi di peptidomimetici potenziali inibitori di falcipaina-2 109
Novel 2H-isoquinolin-3-ones as antiplasmodial falcipain-2 inhibitors 109
Totale 24.267
Salva come PNG Salva come JPEG
Categoria #
all - tutte 98.264
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 98.264
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.061 0 0 0 0 0 0 0 0 0 213 164 684
2021/20221.643 10 350 30 70 86 2 103 61 36 61 295 539
2022/20234.222 367 326 182 300 328 467 84 224 1.779 16 98 51
2023/2024847 91 127 69 198 93 92 16 31 4 46 14 66
2024/20254.394 95 44 105 361 205 48 18 1.059 1.223 200 317 719
2025/202620.422 419 3.321 7.312 1.057 853 2.994 1.443 1.414 1.310 299 0 0
Totale 37.647